483
SRI Krishna Pharmaceuticals Ltd - Unit ISRI Krishna Pharmaceuticals Ltd - Unit I – FDA 483, Sep 1, 2023
Record Details
Sri Krishna Pharmaceuticals Limited - UNIT-I, an API manufacturer in Hyderabad, India, was cited for numerous significant cGMP deficiencies during an FDA inspection. Issues include widespread failures in Quality Unit oversight, inadequate equipment cleaning and validation, deficient out-of-specification and complaint investigations, and an insufficient stability monitoring program. These observations indicate a systemic lack of control over critical manufacturing processes and data integrity.
View Company Profile
ID · 6e5e2af0-2250-4586-b754-3b07e8f471ec
Other documents for SRI Krishna Pharmaceuticals Ltd - Unit I
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.